215 related articles for article (PubMed ID: 37174723)
21. HPV and cancer of the oral cavity.
Hübbers CU; Akgül B
Virulence; 2015; 6(3):244-8. PubMed ID: 25654476
[TBL] [Abstract][Full Text] [Related]
22. Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma.
Lin BM; Wang H; D'Souza G; Zhang Z; Fakhry C; Joseph AW; Drake VE; Sanguineti G; Westra WH; Pai SI
Cancer; 2013 Oct; 119(19):3462-71. PubMed ID: 23861037
[TBL] [Abstract][Full Text] [Related]
23. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
[TBL] [Abstract][Full Text] [Related]
24. The Possible Role of Human Papillomavirus Infection in the prognosis of Oral Squamous Cell Carcinoma in a Northern Israel Population.
Ghantous Y; Akrish S; Leiser Y; Abu El-Naaj I
Isr Med Assoc J; 2018 Mar; 20(3):155-160. PubMed ID: 29527853
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus and oral squamous cell carcinoma: A review of HPV-positive oral squamous cell carcinoma and possible strategies for future.
Jiang S; Dong Y
Curr Probl Cancer; 2017; 41(5):323-327. PubMed ID: 28416242
[TBL] [Abstract][Full Text] [Related]
26. Molecular classification of human papilloma virus-negative head and neck squamous cell carcinomas: Cell cycle-based classifier and prognostic signature.
Gu H; Li T; Beeraka NM; Zheng Y; Zhang X; Song R; Zhou R; Wang X; Sukocheva O; Fan R; Liu J
PLoS One; 2023; 18(10):e0286414. PubMed ID: 37903125
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus and head and neck squamous cell carcinoma in a UK population: Is there an association?
Al-Dabbagh R; Al-Hazmi N; Alhazzazi TY; Barrett AW; Speight PM
Indian J Cancer; 2022; 59(1):65-72. PubMed ID: 33753602
[TBL] [Abstract][Full Text] [Related]
28. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
Snietura M; Brewczynski A; Kopec A; Rutkowski T
Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
[TBL] [Abstract][Full Text] [Related]
29. Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes.
Lee LA; Huang CG; Tsao KC; Liao CT; Kang CJ; Chang KP; Huang SF; Chen IH; Fang TJ; Li HY; Yang SL; Lee LY; Hsueh C; Chen TC; Lin CY; Fan KH; Wang HM; Ng SH; Chang YL; Lai CH; Shih SR; Yen TC
J Clin Virol; 2013 Aug; 57(4):331-7. PubMed ID: 23669598
[TBL] [Abstract][Full Text] [Related]
30. Impact of HPV infection on oral squamous cell carcinoma.
Götz C; Drecoll E; Straub M; Bissinger O; Wolff KD; Kolk A
Oncotarget; 2016 Nov; 7(47):76704-76712. PubMed ID: 27732948
[TBL] [Abstract][Full Text] [Related]
31. The Prevalence of HPV in Oral Cavity Squamous Cell Carcinoma.
Katirachi SK; Grønlund MP; Jakobsen KK; Grønhøj C; von Buchwald C
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851665
[TBL] [Abstract][Full Text] [Related]
32. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
33. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
34. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
Front Public Health; 2022; 10():900294. PubMed ID: 35958856
[TBL] [Abstract][Full Text] [Related]
35. Identification of human papillomavirus (HPV) subtype in oral cancer patients through microarray technology.
Kim SM; Kwon IJ; Myoung H; Lee JH; Lee SK
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):535-543. PubMed ID: 29224043
[TBL] [Abstract][Full Text] [Related]
36. Human Papillomavirus (HPV)-associated Oral Cancers and Treatment Strategies.
Sathish N; Wang X; Yuan Y
J Dent Res; 2014 Jul; 93(7 Suppl):29S-36S. PubMed ID: 24663683
[TBL] [Abstract][Full Text] [Related]
37. The role of human papillomavirus in p16-positive oral cancers.
Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
[TBL] [Abstract][Full Text] [Related]
38. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].
Wittekindt C; Wagner S; Mayer CS; Klußmann JP
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913
[TBL] [Abstract][Full Text] [Related]
39. p16 - a Possible Surrogate Marker for High-Risk Human Papillomaviruses in Oral Cancer?
Sritippho T; Pongsiriwet S; Lertprasertsuke N; Buddhachat K; Sastraruji T; Iamaroon A
Asian Pac J Cancer Prev; 2016; 17(8):4049-57. PubMed ID: 27644660
[TBL] [Abstract][Full Text] [Related]
40. High-risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma.
Ramkumar SP; Simpson MC; Adjei Boakye E; Bukatko AR; Antisdel JL; Massa ST; Osazuwa-Peters N
Cancer; 2023 May; 129(9):1372-1383. PubMed ID: 36808090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
